|Dr. Oliver P. Peoples||Co-Founder, Pres, CEO & Director||434.4k||N/A||1958|
|Dr. Anthony J. Sinskey Ph.D., Sc.D.||Co-Founder & Independent Director||59.78k||N/A||1940|
|Dr. Kristi D. Snell||VP of Research & Chief Science Officer||322.07k||N/A||1968|
|Ms. Lynne H. Brum||VP of Planning & Corp. Communications and Sec.||312.08k||N/A||1964|
|Mr. Charles B. Haaser||VP of Fin., Chief Accounting Officer & Treasurer||N/A||N/A||1956|
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing oilseed Camelina to produce proprietary products; and high value seed traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Yield10 Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.